Boehringer Ingelheim
Ingelheim am Rhein, Germany
Ingelheim am Rhein, Germany
Marco Nebe studied Biomedical Chemistry at the Johannes Gutenberg University Mainz, specializing in Organic Chemistry during his Ph.D, which he earned in 2018 under the guidance of Prof. Dr. Till Opatz. His research focused on developing miscellaneous methods for the synthesis of N-heterocyclic compounds, highlighting his expertise in advanced organic synthesis techniques. Following his Ph.D., he started his industrial career as a PostDoc in Chemical Development at Boehringer Ingelheim. Since 2020, he has been working as a laboratory head in Chemical Development at Boehringer Ingelheim, where he contributes towards designing and optimizing chemical processes for NCE drug substance candidates. His responsibilities include ensuring the safety, robustness, and scalability of chemical processes, as well as meeting stringent quality and cost requirements. Initially, working in early-stage development at the interface to research his role evolved to encompass late-stage development at the interface to routine commercial production for market supply. His experience in both early and late-stage development has equipped him with a comprehensive understanding of the entire lifecycle of drug substance development from the start of development (SOD) through all clinical trial phases and up to preparation of market authorization application (MAA). Following this process, he successfully gained expertise in managing the transition of chemical processes from laboratory to production scale.